{"id":"W4405114312","doi":"10.1038/s41467-024-54415-7","title":"Coupling cellular drug-target engagement to downstream pharmacology with CeTEAM","year":2024,"lang":"en","type":"article","venue":"Nature Communications","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; Université de Montréal","funders":"Canadian Institutes of Health Research; Science for Life Laboratory; Barncancerfonden; Novo Nordisk; Horizon 2020 Framework Programme; Stiftelsen Felix Mindus Bidrag till Leukemiforskningen; Novo Nordisk Fonden; Svenska Sällskapet för Medicinsk Forskning; Cancerfonden; Alfred Österlunds Stiftelse; European Commission; Pain Relief Foundation; Torsten Söderbergs Stiftelse; Michael Smith Health Research BC; Government of Canada; Karolinska Institutet; Loo och Hans Ostermans Stiftelse för Medicinsk Forskning","keywords":"PARP1; Drug discovery; Drug; Biology; Computational biology; Drug development; Target protein; Cell biology; Pharmacology; DNA; Polymerase; Poly ADP ribose polymerase; Biochemistry; Gene","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002427512,0.0005286822,0.0004770464,0.0002469005,0.0001648385,0.0004900932,0.0003840033,0.0004965778,0.002317471],"category_scores_gemma":[0.0003489587,0.0002128744,0.0002346503,0.0002720838,0.0002759844,0.0003254954,0.0004382916,0.0009983911,0.0008107044],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005320309,"about_ca_system_score_gemma":0.0002948183,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003527613,"about_ca_topic_score_gemma":0.0007348112,"domain_scores_codex":[0.9997155,0.00004438529,0.00002004001,0.0000905092,0.00009120838,0.00003837049],"domain_scores_gemma":[0.9998602,0.00004392506,0.00003485203,0.00002913885,0.00001655216,0.00001536626],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00009959263,0.00006363074,0.0001583334,0.00008588132,0.00001226248,0.00004028348,0.00001590696,0.0002741219,0.9919255,0.0002868532,0.0001695358,0.006868144],"study_design_scores_gemma":[0.00001137261,0.0001597485,0.0003454078,0.000002244765,0.000005495901,0.00005798391,0.000004004898,0.001227025,0.9963821,0.00005992999,0.001741117,0.000003566564],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8463079,0.005013447,0.1322263,0.000959505,0.0002405644,0.0007147511,0.002151767,0.001714233,0.01067164],"genre_scores_gemma":[0.9569898,0.002075734,0.03367456,0.0002894133,0.00003280301,0.0003447008,0.0007669422,0.0000941631,0.005731822],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002317471,"threshold_uncertainty_score":0.007752657,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0271126472009105,"score_gpt":0.3666959977836419,"score_spread":0.3395833505827314,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}